Neuropace, Inc. (NPCE) Financials

NPCE Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 107.7 million 87.0 million
2023-09-30 99.3 million 82.9 million
2023-06-30 102.2 million 81.0 million
2023-03-31 106.3 million 78.8 million

NPCE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -3.4 million 2.4 million
2023-09-30 -2.3 million 2.4 million
2023-06-30 -4.4 million 2.7 million
2023-03-31 -9.8 million 2.1 million

NPCE Net Income

No data available :(

NPCE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 66.5 million - 15.4 million
2023-09-30 61.3 million - 15.8 million
2023-06-30 63.6 million 54.9 million 16.2 million
2023-03-31 67.6 million 53.9 million 16.5 million

NPCE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 26.8 million
2023-09-30 26.0 million
2023-06-30 25.5 million
2023-03-31 25.1 million

NPCE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 32000 5.4 million 13.2 million -
2023-09-30 9000 4.8 million 13.4 million -
2023-06-30 - 5.3 million 14.5 million -
2023-03-31 132000 5.3 million 13.4 million -

NPCE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 18.0 million 4.5 million
2023-09-30 16.4 million 4.2 million
2023-06-30 16.5 million 4.5 million
2023-03-31 14.5 million 4.1 million

NPCE

Price: $13.64

52 week price:
3.80
18.15

Earnings Per Share: -1.27 USD

P/E Ratio: -10.80

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Volume: 24800

Market Capitalization: 391.7 million

Links: